Test a glowing scan to help surgeons find tumor tissue
Treatments studied
Part of Cancer clinical trials.
This early-stage study tests an intraoperative imaging approach called “TumorGlow” to help surgeons better identify tumor tissue during surgery. It may help improve the completeness of tumor removal and reduce the chance of recurrence in certain patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are having surgery for a solid tumor or a suspicious tissue area (even if it may turn out to be benign) that may come back
- Your surgical team believes you are well enough to safely have the operation
- You can understand the study and sign the informed consent
- You are not pregnant and are not a child or incarcerated (the study avoids these groups)
- Your high blood pressure is controlled (not uncontrolled or requiring many meds) and you do not have a known iodine/iodide allergy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early (Phase 1) study tests whether a glowing dye called indocyanine green helps surgeons better see nervous system tumor tissue during an operation, with the goal of lowering the chance of tumor coming back locally. It’s for adults whose tumor is expected to be removable and at risk for local recurrence.
This study uses a special dye that makes tumors glow during surgery, helping your surgeon see exactly what to remove and what to leave. It aims to make surgery more precise and safer for people with bone or soft tissue tumors.
This trial tests a dye called indocyanine green (ICG) that makes cancer cells glow under a special camera during surgery. It may help doctors remove more cancer and leave healthy tissue alone.
This trial tests a special imaging tool that helps surgeons see brain tumors more clearly during surgery, so they can remove as much tumor as possible while protecting healthy tissue. It is designed for people already having surgery to remove a brain tumor.
This Phase 2 study tests whether using a fluorescent dye during tumor surgery can help the surgical team better see where the tumor ends. It may help aim for complete removal and lower the chance of the tumor coming back.
This trial uses a special dye called indocyanine green (ICG) during surgery to make giant cell bone tumors glow, helping doctors remove them more accurately. It may lead to better surgical outcomes for people with this tumor type.
Hear when a new Tumor, Solid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.